(Q39418780)

English

Organosulfur derivatives of the HDAC inhibitor valproic acid sensitize human lung cancer cell lines to apoptosis and to cisplatin cytotoxicity

scientific article published in October 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Organosulfur derivatives of the HDAC inhibitor valproic acid sensitize human lung cancer cell lines to apoptosis and to cisplatin cytotoxicity (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

0 references

apoptotic process

0 references

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

object named as

Chiara Arienti

6

0 references

Francesco Fabbri

object named as

Francesco Fabbri

4

0 references

object named as

Paola Ulivi

5

0 references

object named as

Anna Sparatore

7

0 references

object named as

Alice Pasini

9

0 references

author name string

Giovanni Brigliadori

2

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Silvia Carloni

3

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Piero Del Soldato

8

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Dino Amadori

10

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Rosella Silvestrini

11

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Wainer Zoli

12

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

publication date

1 October 2012

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Journal of Cellular Physiology

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

227

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

3389-3396

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Hydrogen sulfide gas has cell growth regulatory role

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24039

21 January 2018

Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction?

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24039

21 January 2018

Hydrogen sulfide mediates the vasoactivity of garlic

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24039

21 January 2018

Special HATs for special occasions: linking histone acetylation to chromatin assembly and gene activation

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24039

21 January 2018

Single-step doxorubicin-selected cancer cells overexpress the ABCG2 drug transporter through epigenetic changes.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24039

21 January 2018

Valproic acid as epigenetic cancer drug: preclinical, clinical and transcriptional effects on solid tumors

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24039

21 January 2018

Matrix metalloproteinase-1 promotes breast cancer angiogenesis and osteolysis in a novel in vivo model

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24039

21 January 2018

The history of cancer epigenetics

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24039

21 January 2018

The epigenetic progenitor origin of human cancer

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24039

21 January 2018

Reversal of drug resistance of hepatocellular carcinoma cells by adenoviral delivery of anti-ABCC2 antisense constructs

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24039

21 January 2018

Molecular and biological features of two new human squamous and adenocarcinoma of the lung cell lines

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24039

21 January 2018

Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24039

21 January 2018

Innovative sequence of docetaxel-gemcitabine based on preclinical data in the treatment of advanced non small cell lung cancer: a phase I study

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24039

21 January 2018

Modulation of angiogenesis by dithiolethione-modified NSAIDs and valproic acid.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24039

21 January 2018

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24039

21 January 2018

Translating the Histone Code

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24039

21 January 2018

Chemoprotection by organosulfur inducers of phase 2 enzymes: dithiolethiones and dithiins

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24039

21 January 2018

Histone deacetylase inhibitors: current status and overview of recent clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24039

21 January 2018

Valproic acid alters chromatin structure by regulation of chromatin modulation proteins

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24039

21 January 2018

Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24039

21 January 2018

Dithiolethione modified valproate and diclofenac increase E-cadherin expression and decrease proliferation of non-small cell lung cancer cells.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24039

21 January 2018

Dietary agents as histone deacetylase inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24039

21 January 2018

Histone deacetylases as targets for dietary cancer preventive agents: lessons learned with butyrate, diallyl disulfide, and sulforaphane

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24039

21 January 2018

Cyclic tetrapeptides bearing a sulfhydryl group potently inhibit histone deacetylases.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24039

21 January 2018

Renal protection by 3H-1,2-dithiole-3-thione against cisplatin through the Nrf2-antioxidant pathway

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24039

21 January 2018

Global cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24039

21 January 2018

New sulfurated derivatives of valproic acid with enhanced histone deacetylase inhibitory activity

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24039

21 January 2018

Doxorubicin- and daunorubicin-glutathione conjugates, but not unconjugated drugs, competitively inhibit leukotriene C4 transport mediated by MRP/GS-X pump

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24039

21 January 2018

Chemoprevention of colon cancer by minor dietary constituents and their synthetic analogues

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24039

21 January 2018

Chemopreventive effect of S-methylmethane thiosulfonate and sulindac administered together during the promotion/progression stages of colon carcinogenesis.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24039

21 January 2018

In vitro and in vivo interaction between cisplatin and topotecan in ovarian carcinoma systems

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24039

21 January 2018

Molecular characterization of cytotoxic and resistance mechanisms induced by NCX 4040, a novel NO-NSAID, in pancreatic cancer cell lines

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24039

21 January 2018

Matrix metalloproteinase 1 (MMP1) is associated with early-onset lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24039

21 January 2018

Adriamycin-induced heart failure: mechanism and modulation

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24039

21 January 2018

New colorimetric cytotoxicity assay for anticancer-drug screening

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24039

21 January 2018

One hundred years of lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24039

21 January 2018

Lung cancer--where are we today? Current advances in staging and nonsurgical treatment.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24039

21 January 2018

Thiol-based SAHA analogues as potent histone deacetylase inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24039

21 January 2018

Hydrogen sulfide regulates cardiac function and structure in adriamycin-induced cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24039

21 January 2018

Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24039

21 January 2018

Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24039

21 January 2018

New histone deacetylase inhibitors as potential therapeutic tools for advanced prostate carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24039

21 January 2018

HDAC family: What are the cancer relevant targets?

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24039

21 January 2018

In vitro preclinical models for a rational design of chemotherapy combinations in human tumors

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24039

21 January 2018

Identifiers

10.1002/JCP.24039

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39418780&oldid=1826605017"